Young Hee Jung

Young Hee Jung

Auto-generated profile, based on publicly available information

Young Hee Jung

Department of Neurology, Hallym Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2022 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
YKYoonjung Kim
Yoonjung Kim
SKSeong Eun Kim
Seong Eun Kim
TKTark Kim
Tark Kim
KYKi Wook Yun
Ki Wook Yun
SLSo Hee Lee
So Hee Lee
YCYong Pil Chong
Yong Pil Chong
Kim Y, et al. Infect Chemother. 2022 Jul;54:e70. https://doi.org/10.3947/ic.2022.0141

1 January 2024 in Infection & Chemotherapy
Verified
Journal Article
Open access
JSJun-Won Seo
Jun-Won Seo
SKSeong Eun Kim
Seong Eun Kim
YKYoonjung Kim
Yoonjung Kim
EKEun-Jung Kim
Eun-Jung Kim
TKTark Kim
Tark Kim
JSJoon Young Song
Joon Young Song
Seo JW, et al. Infect Chemother. 2024 Mar;56:e11. https://doi.org/10.3947/ic.2024.0024

17 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SKSeung joo Kim
Seung joo Kim
DLDong Kyun Lee
Dong Kyun Lee
YJYoung Kyoung Jang
Young Kyoung Jang
HJHyemin Jang
Hyemin Jang
SKSi Eun Kim
Si Eun Kim
HKHee Jin Kim
Hee Jin Kim
White matter hyperintensity (WMH) has been recognised as a surrogate marker of small vessel disease and is associated with cognitive impairment. We investigated the dynamic change in WMH in patients with severe WMH at baseline, and the effects of longitudinal change of WMH volume on cognitive decline and cortical thinning. Eighty-seven patients with subcortical vascular mild cognitive impairment were prospectively recruited from a single referral centre. All of the patients were followed up with annual neuropsychological tests and 3T brain magnetic resonance imaging. The WMH volume was quantified using an automated method and the cortical thickness was measured using surface-based methods. Participants were classified into WMH progression and WMH regression groups based on the delta WMH volume between the baseline and the last follow-up. To investigate the effects of longitudinal change in WMH volume on cognitive decline and cortical thinning, a linear mixed effects model was used. Seventy patients showed WMH progression and 17 showed WMH regression over a three-year period. The WMH progression group showed more rapid cortical thinning in widespread regions compared with the WMH regression group. However, the rate of cognitive decline in language, visuospatial function, memory and executive function, and general cognitive function was not different between the two groups. The results of this study indicated that WMH volume changes are dynamic and WMH progression is associated with more rapid cortical thinning.

1 February 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
NKNak-Hyun Kim
Nak-Hyun Kim
HKHei Lim Koo
Hei Lim Koo
PCPyeong Gyun Choe
Pyeong Gyun Choe
SCShinhye Cheon
Shinhye Cheon
MKMoon Suk Kim
Moon Suk Kim
EKEui Chong Kim
Eui Chong Kim
Vancomycin is frequently inappropriately prescribed, especially as empirical treatment. The aim of this study was to evaluate (i) the amount of inappropriate continued empirical vancomycin use as a proportion of total vancomycin use and (ii) the risk factors associated with inappropriate continued empirical vancomycin use. We reviewed the medical records of adult patients who had been prescribed at least one dose of parenterally administered vancomycin between January and June 2012, in a single tertiary care hospital. When empirically prescribed vancomycin treatment was continued after 96 h without documentation of beta-lactam-resistant Gram-positive microorganisms in clinical specimens with significance, the continuation was considered inappropriate, and the amount used thereafter was considered inappropriately used. We identified risk factors associated with inappropriate continued empirical vancomycin use by multiple logistic regression. During the study period, the amount of parenterally administered vancomycin prescribed was 34.2 defined daily doses (DDDs)/1,000 patient-days (1,084 prescriptions for 971 patients). The amount of inappropriate continued empirical vancomycin use was 8.5 DDDs/1,000 patient-days, which represented 24.9% of the total parenterally administered vancomycin used (8.5/34.2 DDDs/1,000 patient-days). By multivariate analyses, inappropriate continued empirical vancomycin use was independently associated with the absence of any documented etiological organism (adjusted odds ratio [aOR], 1.60 [95% confidence interval {CI}, 1.06 to 2.41]) and suspected central nervous system (CNS) infections (aHR, 2.33 [95% CI, 1.20 to 4.50]). Higher Charlson's comorbidity index scores were inversely associated with inappropriate continued empirical vancomycin use (aHR, 0.90 [95% CI, 0.85 to 0.97]). Inappropriate continued empirical vancomycin use represented 24.9% of the total amount of vancomycin prescribed, which indicates room for improvement.

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YJYoung Hee Jung
Young Hee Jung
EHEun-Hye Ha
Eun-Hye Ha
KCKang Won Choe
Kang Won Choe
Seungbok LeeSeungbok Lee
Seungbok Lee
DJDong Ho Jo
Dong Ho Jo
WLWang Jun Lee
Wang Jun Lee
Jung YH, et al. J Korean Med Sci. 2022 Jun;37(27):e213. https://doi.org/10.3346/jkms.2022.37.e213

1 January 2020 in Dementia and Neurocognitive Disorders
Verified
Journal Article
Open access
PDF file
YJYoung Hee Jung
Young Hee Jung
SLSoyoung Lee
Soyoung Lee
WKWoo Jung Kim
Woo Jung Kim
JLJee Hee Lee
Jee Hee Lee
MKMyung Jong Kim
Myung Jong Kim
HHHyun Jeong Han
Hyun Jeong Han
Jung YH, et al. Dement Neurocogn Disord. 2020 Sep;19(3):86-95. https://doi.org/10.12779/dnd.2020.19.3.86